Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age

被引：0
|
作者：
Raffaele Addeo
Vincenzo Faiola
Rosario Guarrasi
Liliana Montella
Bruno Vincenzi
Elena Capasso
Gregorio Cennamo
Maria Saveria Rotundo
Pierosandro Tagliaferri
Michele Caraglia
Salvatore Del Prete
机构：
[1] “S.Giovanni di Dio” Hospital,Oncology Unit, U.O.C. Oncology
[2] Campus Biomedico University,Section of Oncology
[3] University Magna Grǽcia of Catanzaro and Oncology Center “T. Campanella”,Department of Experimental and Clinical Medicine
[4] National Institute of Tumours of Naples,Experimental Pharmacology Unit, INT Pascale
[5] Via Mariano Semmola,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Metastatic breast cancer; Vinorelbine; Liposomal pegylated doxorubicin; QoL; Elderly patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel as first line therapy in metastatic breast cancer
    Fulfaro, F.
    Valerio, M. R.
    Cicero, G.
    Rinaldi, G.
    Intrivici, C.
    Pizzo, T.
    Crosta, A.
    Scibilia, C.
    Gebbia, N.
    ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI11
  • [42] Non-pegylated Liposomal Doxorubicin (Myocet ®) Plus Docetaxel (Taxotere ®) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study
    Imperatori, L.
    Lippe, P.
    Trapuzzano, C.
    Laici, G.
    Cappelletti, C.
    Tamburrano, T.
    Mattioli, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S353 - S353
  • [43] A COMPARISON OF FIRST-LINE TREATMENT WITH GEMCITABINE PLUS DOCETAXEL VERSUS GEMCITABINE PLUS VINORELBINE IN WOMEN WITH METASTATIC BREAST CANCER
    Bensalem, A.
    Bouzid, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer Reply
    Sparano, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : E129 - E130
  • [45] A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer
    Chow, Louis Wing-Cheong
    Yip, Adrian Yun-San
    Lang, Brian Hung-Hin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (02): : 133 - 138
  • [46] Pegylated liposomal doxorubicin and vinorelbine in metastatic breast cancer: Final results of a phase II trial
    Elsaid, A. A.
    Awad, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Capecitabine and vinorelbine as first-line treatment in elderly patients (≥65 years) with metastatic breast cancer -: A phase II trial (SAKK 25/99)
    Hess, D.
    Koeberle, D.
    Thuerlimann, B.
    Pagani, O.
    Schoenenberger, A.
    Mattmann, S.
    Rochlitz, C.
    Rauch, D.
    Schuller, J. C.
    Ballabeni, P.
    Ribi, K.
    ONCOLOGY, 2007, 73 (3-4) : 228 - 237
  • [48] Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer
    Rossi, A
    Gridelli, C
    Gebbia, V
    Rosati, G
    Tortoriello, A
    Maione, P
    Borsellino, N
    Rossi, N
    Pisano, A
    Colantuoni, G
    Iaffaioli, RV
    Castaldo, V
    Manzione, L
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1657 - 1664
  • [49] A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG
    Smorenburg, C. H.
    de Groot, S. M.
    van Leeuwen-Stok, A. E.
    Hamaker, M. E.
    Wymenga, A. N.
    de Graaf, H.
    de Jongh, F. E.
    Braun, J. J.
    Los, M.
    Maartense, E.
    van Tinteren, H.
    Nortier, J. W. R.
    Seynaeve, C.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 599 - 605
  • [50] Chemotherapy based on liposomal doxorubicin (Myocet (R)) in metastatic breast cancer after prior first-line treatment with anthracycline
    Hanslik, Jerzy
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 : A28 - A30
12345